Arbutus Biopharma Corporation (ABUS): Price and Financial Metrics
ABUS Price/Volume Stats
| Current price | $3.44 | 52-week high | $4.72 |
| Prev. close | $3.49 | 52-week low | $1.79 |
| Day low | $3.42 | Volume | 626,500 |
| Day high | $3.54 | Avg. volume | 1,108,128 |
| 50-day MA | $3.92 | Dividend yield | N/A |
| 200-day MA | $3.38 | Market Cap | 651.85M |
ABUS Stock Price Chart Interactive Chart >
Arbutus Biopharma Corporation (ABUS) Company Bio
Arbutus Biopharma Corporation, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of chronic hepatitis B (HBV) infections in Canada and the United States. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. The company is based in Burnaby, Canada.
ABUS Price Returns
| 1-mo | -14.64% |
| 3-mo | -11.57% |
| 6-mo | 4.56% |
| 1-year | 86.96% |
| 3-year | 10.61% |
| 5-year | 124.84% |
| YTD | 37.60% |
| 2023 | 7.30% |
| 2022 | -40.10% |
| 2021 | 9.58% |
| 2020 | 27.70% |
| 2019 | -27.42% |
Continue Researching ABUS
Want to do more research on Arbutus Biopharma Corp's stock and its price? Try the links below:Arbutus Biopharma Corp (ABUS) Stock Price | Nasdaq
Arbutus Biopharma Corp (ABUS) Stock Quote, History and News - Yahoo Finance
Arbutus Biopharma Corp (ABUS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...